Total IgE levels are linked to the response of chronic spontaneous urticaria patients to omalizumab

Allergy. 2018 Dec;73(12):2406-2408. doi: 10.1111/all.13586. Epub 2018 Sep 25.

Affiliations

¹ The Department of Dermatology and Allergy, Allergie-Centrum-Charité, Charité - Universitätsmedizin Berlin, Berlin, Germany.
² The Division of Allergy and Clinical Immunology, St Michael's Hospital, University of Toronto, Toronto, Ontario, Canada.
³ The Department of Dermatology, Hospital del Mar, iMIM, Universitat Autonoma of Barcelona, Barcelona, Spain.
⁴ The Department of Dermatology, University Medical Center Mainz, Mainz, Germany.

PMID: 30076605
DOI: 10.1111/all.13586

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Anti-Allergic Agents / therapeutic use
Chronic Disease
Drug Monitoring
Humans
Immunoglobulin E / blood*
Omalizumab / therapeutic use*
Urticaria / drug therapy*

Substances

Anti-Allergic Agents
Omalizumab
Immunoglobulin E

Grants and funding